|
|
Volumn 9, Issue 2, 2002, Pages 219-227
|
|
Inhibitors of AP-1 and NF-ΚB mediated transcriptional activation: Therapeutic potential in autoimmune diseases and structural diversity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCYSTEINE;
CAFFEIC ACID PHENETHYL ESTER;
CAPSAICIN;
CHEMOKINE;
CURCUMIN;
CYCLOPENTENONE DERIVATIVE;
CYTOKINE;
DEXAMETHASONE;
GELDANAMYCIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HERBIMYCIN;
INTERLEUKIN 1;
INTERLEUKIN 13;
INTERLEUKIN 2;
INTERLEUKIN 3;
INTERLEUKIN 4;
INTERLEUKIN 5;
INTERLEUKIN 6;
INTERLEUKIN 8;
LACTACYSTIN;
MATRIX METALLOPROTEINASE;
N (2 FLUORENYL)ACETAMIDE;
NICOTINE;
NUCLEAR FACTOR;
PROTEIN INHIBITOR;
RETINOID DERIVATIVE;
TRANSCRIPTION FACTOR AP 1;
TRANSCRIPTION FACTOR NFAT;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG STRUCTURE;
STRUCTURE ACTIVITY RELATION;
T LYMPHOCYTE ACTIVATION;
TRANSCRIPTION INITIATION;
|
|
EID: 0036230293
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867023371265 Document Type: Article |
|
Times cited : (67)
|
|
References (55)
|
